A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Clinical trial NCT05660447 · UNKNOWN

Trial details

NCT number: NCT05660447
Sponsor: Wills Eye
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy

Start date: 2023-02-06
Primary completion: 2024-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.